365 related articles for article (PubMed ID: 11775910)
1. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution.
Mäenpää JU; Kangasniemi K; Luukkaala T
Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
5. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
8. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopy-assisted vaginal pelvic exenteration.
Ferron G; Querleu D; Martel P; Letourneur B; Soulié M
Gynecol Oncol; 2006 Mar; 100(3):551-5. PubMed ID: 16249020
[TBL] [Abstract][Full Text] [Related]
10. [Laparoscopy-assisted vaginal pelvic exenteration].
Ferron G; Querleu D; Martel P; Chopin N; Soulié M
Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
[TBL] [Abstract][Full Text] [Related]
11. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
Kraybill WG; Lopez MJ; Bricker EM
Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
[TBL] [Abstract][Full Text] [Related]
14. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for recurrent endometrial cancer.
Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
[TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
[TBL] [Abstract][Full Text] [Related]
17. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
Schmidt AM; Imesch P; Fink D; Egger H
Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
[TBL] [Abstract][Full Text] [Related]
18. [Total pelvic exenteration in the treatment of advanced pelvic cancer].
Mitulescu G; Ungureanu C; Gluck G; Stîngu C; Mitulescu D; Stănculeanu D; Sgarbură O; Tulbure D; Popescu I
Chirurgia (Bucur); 2007; 102(2):143-54. PubMed ID: 17615915
[TBL] [Abstract][Full Text] [Related]
19. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990.
Miller B; Morris M; Gershenson DM; Levenback CL; Burke TW
Gynecol Oncol; 1995 Feb; 56(2):207-10. PubMed ID: 7896187
[TBL] [Abstract][Full Text] [Related]
20. Pelvic exenteration: a perspective from a regional cancer center in India.
Pandey D; Zaidi S; Mahajan V; Kannan R
Indian J Cancer; 2004; 41(3):109-14. PubMed ID: 15472408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
